Achim H P Krauss, Francesco Impagnatiello, Carol B Toris, David C Gale, Ganesh Prasanna, Valentina Borghi, Valerio Chiroli, Wesley K M Chong, Samantha T Carreiro, Ennio Ongini. Exp Eye Res 2011
Times Cited: 77
Times Cited: 77
Times Cited
Times Co-cited
Similarity
A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER study.
Robert N Weinreb, Tuyen Ong, Baldo Scassellati Sforzolini, Jason L Vittitow, Kuldev Singh, Paul L Kaufman. Br J Ophthalmol 2015
Robert N Weinreb, Tuyen Ong, Baldo Scassellati Sforzolini, Jason L Vittitow, Kuldev Singh, Paul L Kaufman. Br J Ophthalmol 2015
44
Nitric oxide (NO): an emerging target for the treatment of glaucoma.
Megan E Cavet, Jason L Vittitow, Francesco Impagnatiello, Ennio Ongini, Elena Bastia. Invest Ophthalmol Vis Sci 2014
Megan E Cavet, Jason L Vittitow, Francesco Impagnatiello, Ennio Ongini, Elena Bastia. Invest Ophthalmol Vis Sci 2014
37
Latanoprostene Bunod 0.024% versus Timolol Maleate 0.5% in Subjects with Open-Angle Glaucoma or Ocular Hypertension: The APOLLO Study.
Robert N Weinreb, Baldo Scassellati Sforzolini, Jason Vittitow, Jeffrey Liebmann. Ophthalmology 2016
Robert N Weinreb, Baldo Scassellati Sforzolini, Jason Vittitow, Jeffrey Liebmann. Ophthalmology 2016
41
eNOS, a pressure-dependent regulator of intraocular pressure.
W Daniel Stamer, Yuan Lei, Alexandra Boussommier-Calleja, Darryl R Overby, C Ross Ethier. Invest Ophthalmol Vis Sci 2011
W Daniel Stamer, Yuan Lei, Alexandra Boussommier-Calleja, Darryl R Overby, C Ross Ethier. Invest Ophthalmol Vis Sci 2011
31
Characterization of soluble guanylate cyclase in NO-induced increases in aqueous humor outflow facility and in the trabecular meshwork.
Dorette Z Ellis, William M Dismuke, Binna M Chokshi. Invest Ophthalmol Vis Sci 2009
Dorette Z Ellis, William M Dismuke, Binna M Chokshi. Invest Ophthalmol Vis Sci 2009
47
Comparison of Latanoprostene Bunod 0.024% and Timolol Maleate 0.5% in Open-Angle Glaucoma or Ocular Hypertension: The LUNAR Study.
Felipe A Medeiros, Keith R Martin, James Peace, Baldo Scassellati Sforzolini, Jason L Vittitow, Robert N Weinreb. Am J Ophthalmol 2016
Felipe A Medeiros, Keith R Martin, James Peace, Baldo Scassellati Sforzolini, Jason L Vittitow, Robert N Weinreb. Am J Ophthalmol 2016
42
Relaxation of trabecular meshwork and ciliary muscle by release of nitric oxide.
M Wiederholt, A Sturm, A Lepple-Wienhues. Invest Ophthalmol Vis Sci 1994
M Wiederholt, A Sturm, A Lepple-Wienhues. Invest Ophthalmol Vis Sci 1994
29
NO-induced regulation of human trabecular meshwork cell volume and aqueous humor outflow facility involve the BKCa ion channel.
William M Dismuke, Chigozirim C Mbadugha, Dorette Z Ellis. Am J Physiol Cell Physiol 2008
William M Dismuke, Chigozirim C Mbadugha, Dorette Z Ellis. Am J Physiol Cell Physiol 2008
29
A novel nitric oxide releasing prostaglandin analog, NCX 125, reduces intraocular pressure in rabbit, dog, and primate models of glaucoma.
Valentina Borghi, Elena Bastia, Massimiliano Guzzetta, Valerio Chiroli, Carol B Toris, Minerva R Batugo, Samantha T Carreiro, Wesley K M Chong, David C Gale, David J Kucera,[...]. J Ocul Pharmacol Ther 2010
Valentina Borghi, Elena Bastia, Massimiliano Guzzetta, Valerio Chiroli, Carol B Toris, Minerva R Batugo, Samantha T Carreiro, Wesley K M Chong, David C Gale, David J Kucera,[...]. J Ocul Pharmacol Ther 2010
37
Nitric oxide/guanylate cyclase pathways and flow in anterior segment perfusion.
Andrea Schneemann, Berlinde G Dijkstra, Thomas J van den Berg, Willem Kamphuis, Philip F J Hoyng. Graefes Arch Clin Exp Ophthalmol 2002
Andrea Schneemann, Berlinde G Dijkstra, Thomas J van den Berg, Willem Kamphuis, Philip F J Hoyng. Graefes Arch Clin Exp Ophthalmol 2002
37
Nitrovasodilators as a new class of ocular hypotensive agents.
J A Nathanson. J Pharmacol Exp Ther 1992
J A Nathanson. J Pharmacol Exp Ther 1992
28
Nitric oxide and cyclic GMP enhance aqueous humor outflow facility in rabbits.
Hanna Kotikoski, Heikki Vapaatalo, Olli Oksala. Curr Eye Res 2003
Hanna Kotikoski, Heikki Vapaatalo, Olli Oksala. Curr Eye Res 2003
31
Effect of nitric oxide on anterior segment physiology in monkeys.
Galen W Heyne, Julie A Kiland, Paul L Kaufman, B'Ann T Gabelt. Invest Ophthalmol Vis Sci 2013
Galen W Heyne, Julie A Kiland, Paul L Kaufman, B'Ann T Gabelt. Invest Ophthalmol Vis Sci 2013
42
Regulation of Endothelin-1-Induced Trabecular Meshwork Cell Contractility by Latanoprostene Bunod.
Megan E Cavet, Thomas R Vollmer, Karen L Harrington, Karl VanDerMeid, Mary E Richardson. Invest Ophthalmol Vis Sci 2015
Megan E Cavet, Thomas R Vollmer, Karen L Harrington, Karl VanDerMeid, Mary E Richardson. Invest Ophthalmol Vis Sci 2015
63
Long-term Safety and Efficacy of Latanoprostene Bunod 0.024% in Japanese Subjects with Open-Angle Glaucoma or Ocular Hypertension: The JUPITER Study.
Kazuhide Kawase, Jason L Vittitow, Robert N Weinreb, Makoto Araie. Adv Ther 2016
Kazuhide Kawase, Jason L Vittitow, Robert N Weinreb, Makoto Araie. Adv Ther 2016
53
Alterations of ocular nitric oxide synthase in human glaucoma.
J A Nathanson, M McKee. Invest Ophthalmol Vis Sci 1995
J A Nathanson, M McKee. Invest Ophthalmol Vis Sci 1995
25
Nitric oxide proxies and ocular perfusion pressure in primary open angle glaucoma.
F Galassi, G Renieri, A Sodi, F Ucci, L Vannozzi, E Masini. Br J Ophthalmol 2004
F Galassi, G Renieri, A Sodi, F Ucci, L Vannozzi, E Masini. Br J Ophthalmol 2004
25
Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial.
Anders Heijl, M Cristina Leske, Bo Bengtsson, Leslie Hyman, Boel Bengtsson, Mohamed Hussein. Arch Ophthalmol 2002
Anders Heijl, M Cristina Leske, Bo Bengtsson, Leslie Hyman, Boel Bengtsson, Mohamed Hussein. Arch Ophthalmol 2002
24
Endogenous regulation of human Schlemm's canal cell volume by nitric oxide signaling.
Dorette Z Ellis, Najam A Sharif, William M Dismuke. Invest Ophthalmol Vis Sci 2010
Dorette Z Ellis, Najam A Sharif, William M Dismuke. Invest Ophthalmol Vis Sci 2010
33
Identification of an extensive system of nitric oxide-producing cells in the ciliary muscle and outflow pathway of the human eye.
J A Nathanson, M McKee. Invest Ophthalmol Vis Sci 1995
J A Nathanson, M McKee. Invest Ophthalmol Vis Sci 1995
23
The number of people with glaucoma worldwide in 2010 and 2020.
H A Quigley, A T Broman. Br J Ophthalmol 2006
H A Quigley, A T Broman. Br J Ophthalmol 2006
23
Efficacy of Latanoprostene Bunod 0.024% Compared With Timolol 0.5% in Lowering Intraocular Pressure Over 24 Hours.
John H K Liu, John R Slight, Jason L Vittitow, Baldo Scassellati Sforzolini, Robert N Weinreb. Am J Ophthalmol 2016
John H K Liu, John R Slight, Jason L Vittitow, Baldo Scassellati Sforzolini, Robert N Weinreb. Am J Ophthalmol 2016
46
A dual acting compound with latanoprost amide and nitric oxide releasing properties, shows ocular hypotensive effects in rabbits and dogs.
F Impagnatiello, V Borghi, D C Gale, M Batugo, M Guzzetta, S Brambilla, S T Carreiro, W K M Chong, G Prasanna, V Chiroli,[...]. Exp Eye Res 2011
F Impagnatiello, V Borghi, D C Gale, M Batugo, M Guzzetta, S Brambilla, S T Carreiro, W K M Chong, G Prasanna, V Chiroli,[...]. Exp Eye Res 2011
65
Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial.
M Cristina Leske, Anders Heijl, Mohamed Hussein, Bo Bengtsson, Leslie Hyman, Eugene Komaroff. Arch Ophthalmol 2003
M Cristina Leske, Anders Heijl, Mohamed Hussein, Bo Bengtsson, Leslie Hyman, Eugene Komaroff. Arch Ophthalmol 2003
22
Decreased nitric oxide production in primary open-angle glaucoma.
S Doganay, C Evereklioglu, Y Turkoz, H Er. Eur J Ophthalmol 2002
S Doganay, C Evereklioglu, Y Turkoz, H Er. Eur J Ophthalmol 2002
25
Nitrovasodilator effects on intraocular pressure and outflow facility in monkeys.
J S Schuman, K Erickson, J A Nathanson. Exp Eye Res 1994
J S Schuman, K Erickson, J A Nathanson. Exp Eye Res 1994
20
The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.
Michael A Kass, Dale K Heuer, Eve J Higginbotham, Chris A Johnson, John L Keltner, J Philip Miller, Richard K Parrish, M Roy Wilson, Mae O Gordon. Arch Ophthalmol 2002
Michael A Kass, Dale K Heuer, Eve J Higginbotham, Chris A Johnson, John L Keltner, J Philip Miller, Richard K Parrish, M Roy Wilson, Mae O Gordon. Arch Ophthalmol 2002
20
Aqueous Humor Outflow Physiology in NOS3 Knockout Mice.
Yuan Lei, Xuejin Zhang, Maomao Song, Jihong Wu, Xinghuai Sun. Invest Ophthalmol Vis Sci 2015
Yuan Lei, Xuejin Zhang, Maomao Song, Jihong Wu, Xinghuai Sun. Invest Ophthalmol Vis Sci 2015
43
Evaluation of the Effect of Latanoprostene Bunod Ophthalmic Solution, 0.024% in Lowering Intraocular Pressure over 24 h in Healthy Japanese Subjects.
Makoto Araie, Baldo Scassellati Sforzolini, Jason Vittitow, Robert N Weinreb. Adv Ther 2015
Makoto Araie, Baldo Scassellati Sforzolini, Jason Vittitow, Robert N Weinreb. Adv Ther 2015
61
Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis.
Yih-Chung Tham, Xiang Li, Tien Y Wong, Harry A Quigley, Tin Aung, Ching-Yu Cheng. Ophthalmology 2014
Yih-Chung Tham, Xiang Li, Tien Y Wong, Harry A Quigley, Tin Aung, Ching-Yu Cheng. Ophthalmology 2014
20
Endothelial nitric oxide synthase gene variants and primary open-angle glaucoma: interactions with sex and postmenopausal hormone use.
Jae Hee Kang, Janey L Wiggs, Bernard A Rosner, Susan E Hankinson, Wael Abdrabou, Bao Jian Fan, Jonathan Haines, Louis R Pasquale. Invest Ophthalmol Vis Sci 2010
Jae Hee Kang, Janey L Wiggs, Bernard A Rosner, Susan E Hankinson, Wael Abdrabou, Bao Jian Fan, Jonathan Haines, Louis R Pasquale. Invest Ophthalmol Vis Sci 2010
19
Comparison of nitric oxide donors in lowering intraocular pressure in rabbits: role of cyclic GMP.
Hanna Kotikoski, Päivi Alajuuma, Eeva Moilanen, Pertteli Salmenperä, Olli Oksala, Pekka Laippala, Heikki Vapaatalo. J Ocul Pharmacol Ther 2002
Hanna Kotikoski, Päivi Alajuuma, Eeva Moilanen, Pertteli Salmenperä, Olli Oksala, Pekka Laippala, Heikki Vapaatalo. J Ocul Pharmacol Ther 2002
22
Concentration-related effects of nitric oxide and endothelin-1 on human trabecular meshwork cell contractility.
W Michael Dismuke, Jin Liang, Darryl R Overby, W Daniel Stamer. Exp Eye Res 2014
W Michael Dismuke, Jin Liang, Darryl R Overby, W Daniel Stamer. Exp Eye Res 2014
25
The pathophysiology and treatment of glaucoma: a review.
Robert N Weinreb, Tin Aung, Felipe A Medeiros. JAMA 2014
Robert N Weinreb, Tin Aung, Felipe A Medeiros. JAMA 2014
18
Role of nitric oxide in murine conventional outflow physiology.
Jason Y H Chang, W Daniel Stamer, Jacques Bertrand, A Thomas Read, Catherine M Marando, C Ross Ethier, Darryl R Overby. Am J Physiol Cell Physiol 2015
Jason Y H Chang, W Daniel Stamer, Jacques Bertrand, A Thomas Read, Catherine M Marando, C Ross Ethier, Darryl R Overby. Am J Physiol Cell Physiol 2015
19
Intraocular Pressure-Lowering Activity of NCX 470, a Novel Nitric Oxide-Donating Bimatoprost in Preclinical Models.
Francesco Impagnatiello, Carol B Toris, Minerva Batugo, Ganesh Prasanna, Valentina Borghi, Elena Bastia, Ennio Ongini, Achim H P Krauss. Invest Ophthalmol Vis Sci 2015
Francesco Impagnatiello, Carol B Toris, Minerva Batugo, Ganesh Prasanna, Valentina Borghi, Elena Bastia, Ennio Ongini, Achim H P Krauss. Invest Ophthalmol Vis Sci 2015
51
Soluble guanylate cyclase α1-deficient mice: a novel murine model for primary open angle glaucoma.
Emmanuel S Buys, Yu-Chieh Ko, Clemens Alt, Sarah R Hayton, Alexander Jones, Laurel T Tainsh, Ruiyi Ren, Andrea Giani, Maeva Clerté, Emma Abernathy,[...]. PLoS One 2013
Emmanuel S Buys, Yu-Chieh Ko, Clemens Alt, Sarah R Hayton, Alexander Jones, Laurel T Tainsh, Ruiyi Ren, Andrea Giani, Maeva Clerté, Emma Abernathy,[...]. PLoS One 2013
26
Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial.
David F Garway-Heath, David P Crabb, Catey Bunce, Gerassimos Lascaratos, Francesca Amalfitano, Nitin Anand, Augusto Azuara-Blanco, Rupert R Bourne, David C Broadway, Ian A Cunliffe,[...]. Lancet 2015
David F Garway-Heath, David P Crabb, Catey Bunce, Gerassimos Lascaratos, Francesca Amalfitano, Nitin Anand, Augusto Azuara-Blanco, Rupert R Bourne, David C Broadway, Ian A Cunliffe,[...]. Lancet 2015
15
Latanoprostene bunod ophthalmic solution 0.024% for IOP lowering in glaucoma and ocular hypertension.
Paul L Kaufman. Expert Opin Pharmacother 2017
Paul L Kaufman. Expert Opin Pharmacother 2017
37
The Role of Nitric Oxide in the Intraocular Pressure Lowering Efficacy of Latanoprostene Bunod: Review of Nonclinical Studies.
Megan E Cavet, Heleen H DeCory. J Ocul Pharmacol Ther 2018
Megan E Cavet, Heleen H DeCory. J Ocul Pharmacol Ther 2018
41
Latanoprostene Bunod 0.024% in Subjects With Open-angle Glaucoma or Ocular Hypertension: Pooled Phase 3 Study Findings.
Robert N Weinreb, Jeffrey M Liebmann, Keith R Martin, Paul L Kaufman, Jason L Vittitow. J Glaucoma 2018
Robert N Weinreb, Jeffrey M Liebmann, Keith R Martin, Paul L Kaufman, Jason L Vittitow. J Glaucoma 2018
32
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators.
Claudiu T Supuran. Nat Rev Drug Discov 2008
Claudiu T Supuran. Nat Rev Drug Discov 2008
14
Current understanding of conventional outflow dysfunction in glaucoma.
W Daniel Stamer, Ted S Acott. Curr Opin Ophthalmol 2012
W Daniel Stamer, Ted S Acott. Curr Opin Ophthalmol 2012
14
Regulation of intraocular pressure by soluble and membrane guanylate cyclases and their role in glaucoma.
Emmanuel S Buys, Lincoln R Potter, Louis R Pasquale, Bruce R Ksander. Front Mol Neurosci 2014
Emmanuel S Buys, Lincoln R Potter, Louis R Pasquale, Bruce R Ksander. Front Mol Neurosci 2014
32
Ocular hypotensive effect of the Rho kinase inhibitor AR-12286 in patients with glaucoma and ocular hypertension.
Robert D Williams, Gary D Novack, Thomas van Haarlem, Casey Kopczynski. Am J Ophthalmol 2011
Robert D Williams, Gary D Novack, Thomas van Haarlem, Casey Kopczynski. Am J Ophthalmol 2011
12
Novel ocular antihypertensive compounds in clinical trials.
June Chen, Stephen A Runyan, Michael R Robinson. Clin Ophthalmol 2011
June Chen, Stephen A Runyan, Michael R Robinson. Clin Ophthalmol 2011
12
A new approach to antiglaucoma drugs: carbonic anhydrase inhibitors with or without NO donating moieties. Mechanism of action and preliminary pharmacology.
Francesca Fabrizi, Francesco Mincione, Teresa Somma, Gabriele Scozzafava, Fernando Galassi, Emanuela Masini, Francesco Impagnatiello, Claudiu T Supuran. J Enzyme Inhib Med Chem 2012
Francesca Fabrizi, Francesco Mincione, Teresa Somma, Gabriele Scozzafava, Fernando Galassi, Emanuela Masini, Francesco Impagnatiello, Claudiu T Supuran. J Enzyme Inhib Med Chem 2012
12
Potent reduction of intraocular pressure by nipradilol plus latanoprost in ocular hypertensive rabbits.
Masahiro Orihashi, Yuichiro Shima, Hiroshi Tsuneki, Ikuko Kimura. Biol Pharm Bull 2005
Masahiro Orihashi, Yuichiro Shima, Hiroshi Tsuneki, Ikuko Kimura. Biol Pharm Bull 2005
32
Decreased intraocular pressure induced by nitric oxide donors is correlated to nitrite production in the rabbit eye.
F F Behar-Cohen, O Goureau, F D'Hermies, Y Courtois. Invest Ophthalmol Vis Sci 1996
F F Behar-Cohen, O Goureau, F D'Hermies, Y Courtois. Invest Ophthalmol Vis Sci 1996
12
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.